Schering-Plough declined to comment on the new campaign, citing company policy. BBDO referred all calls to the client. In its second quarter earnings report, Schering-Plough cited Nasonex as one of its top brand performers. The company also reported higher overall promotional expenditures for the first half of , but the figures weren't broken down by brand. Nasonex was the sixth most advertised brand in based on its direct to consumer expenditures, according to Verispan's DTC audit, which was released this summer.
Advertising expenditures for the two brands ran neck in neck in , with Flonase coming in at number seven on Verispan's list of most advertised brands.
The top three most advertised brands in were Nexium esomeprazole , Lunesta eszopiclone , and Vytorin ezetimibe, simvastatin. Nasonex Bee Buzzes New Message. August 30, The Nasonex Bee is buzzing a new tune. Back in , she presented to the FDA a study showing that when drug ads listed benefits, the images on the screen matched the voiceover and moved slowly.
But when side effects were listed, the images often became mis-matched to the voiceover and moved much faster or were more distracting. Day's infamous example was of Schering-Plough 's Nasonex ads, featuring a talking bee voiced by Antonio Banderas.
Day counted the wing-flaps of the bee and found they fluttered faster during side effect information that during benefit information. The result was that viewers found it more difficult to remember the side effects than the benefits. You can see Day's original presentation here.
Day's ideas seem to have been written wholesale into the new guidelines. The FDA gives an example:.
0コメント